| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 25 | 2020 | 212 | 4.270 |
Why?
|
| Connexin 43 | 4 | 2017 | 62 | 1.640 |
Why?
|
| Foreign-Body Reaction | 5 | 2018 | 24 | 1.560 |
Why?
|
| Biocompatible Materials | 10 | 2020 | 247 | 1.350 |
Why?
|
| Hydrogels | 7 | 2020 | 54 | 1.200 |
Why?
|
| Printing, Three-Dimensional | 7 | 2021 | 31 | 1.190 |
Why?
|
| Collagen | 13 | 2018 | 636 | 1.140 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2018 | 234 | 1.110 |
Why?
|
| Wound Healing | 8 | 2015 | 260 | 1.030 |
Why?
|
| Bioprinting | 4 | 2020 | 11 | 1.020 |
Why?
|
| Prostheses and Implants | 5 | 2018 | 159 | 0.990 |
Why?
|
| Hernia, Ventral | 6 | 2009 | 35 | 0.980 |
Why?
|
| Tissue Scaffolds | 7 | 2020 | 111 | 0.940 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 314 | 0.880 |
Why?
|
| Neovascularization, Physiologic | 7 | 2015 | 164 | 0.770 |
Why?
|
| Microtubules | 2 | 2017 | 104 | 0.700 |
Why?
|
| Collagen Type I | 12 | 2018 | 175 | 0.630 |
Why?
|
| Microdissection | 1 | 2018 | 15 | 0.630 |
Why?
|
| Peptide Fragments | 3 | 2015 | 483 | 0.620 |
Why?
|
| Rats | 28 | 2018 | 5300 | 0.600 |
Why?
|
| Satellite Cells, Skeletal Muscle | 5 | 2015 | 12 | 0.590 |
Why?
|
| Myocytes, Cardiac | 6 | 2009 | 442 | 0.580 |
Why?
|
| Animals | 43 | 2020 | 20880 | 0.570 |
Why?
|
| Muscle, Skeletal | 6 | 2015 | 396 | 0.560 |
Why?
|
| Bioartificial Organs | 1 | 2015 | 3 | 0.540 |
Why?
|
| Pancreas, Artificial | 1 | 2015 | 4 | 0.540 |
Why?
|
| Biomimetic Materials | 1 | 2016 | 20 | 0.540 |
Why?
|
| Peptides | 2 | 2020 | 455 | 0.510 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 87 | 0.510 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2015 | 101 | 0.490 |
Why?
|
| Receptors, Purinergic | 1 | 2014 | 10 | 0.470 |
Why?
|
| General Surgery | 1 | 2015 | 95 | 0.470 |
Why?
|
| Pancreatitis, Chronic | 1 | 2015 | 168 | 0.460 |
Why?
|
| Kidney | 1 | 2018 | 945 | 0.440 |
Why?
|
| Abdominal Wound Closure Techniques | 1 | 2013 | 4 | 0.440 |
Why?
|
| Educational Measurement | 1 | 2015 | 254 | 0.440 |
Why?
|
| Inflammation | 4 | 2015 | 1030 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 529 | 0.380 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 839 | 0.360 |
Why?
|
| Cells, Cultured | 10 | 2015 | 2673 | 0.350 |
Why?
|
| Tensile Strength | 4 | 2017 | 90 | 0.330 |
Why?
|
| Tissue Transplantation | 1 | 2009 | 9 | 0.330 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2018 | 2083 | 0.330 |
Why?
|
| Wounds and Injuries | 3 | 2008 | 334 | 0.330 |
Why?
|
| Endothelial Cells | 5 | 2017 | 384 | 0.310 |
Why?
|
| Silicones | 4 | 2018 | 32 | 0.310 |
Why?
|
| Implants, Experimental | 2 | 2004 | 15 | 0.310 |
Why?
|
| Heart Valves | 4 | 2012 | 171 | 0.310 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2008 | 46 | 0.310 |
Why?
|
| Xenobiotics | 1 | 2007 | 17 | 0.300 |
Why?
|
| Toxicity Tests | 1 | 2007 | 26 | 0.300 |
Why?
|
| Extracellular Matrix | 7 | 2020 | 493 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2020 | 219 | 0.290 |
Why?
|
| Alginates | 3 | 2015 | 35 | 0.280 |
Why?
|
| Surgically-Created Structures | 1 | 2006 | 3 | 0.280 |
Why?
|
| Fibroblasts | 6 | 2017 | 902 | 0.270 |
Why?
|
| Humans | 36 | 2021 | 68549 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2016 | 333 | 0.260 |
Why?
|
| Cattle | 7 | 2018 | 475 | 0.250 |
Why?
|
| Signal Transduction | 2 | 2014 | 2689 | 0.250 |
Why?
|
| Cellulose, Oxidized | 1 | 2004 | 3 | 0.250 |
Why?
|
| Stromal Cells | 4 | 2015 | 113 | 0.240 |
Why?
|
| Diabetes Complications | 1 | 2006 | 249 | 0.240 |
Why?
|
| Pericardium | 4 | 2009 | 97 | 0.230 |
Why?
|
| Microvessels | 2 | 2020 | 43 | 0.230 |
Why?
|
| Regeneration | 3 | 2010 | 105 | 0.220 |
Why?
|
| Software | 2 | 2016 | 418 | 0.220 |
Why?
|
| Models, Theoretical | 2 | 2017 | 384 | 0.210 |
Why?
|
| Myocardium | 4 | 2004 | 1204 | 0.210 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2012 | 144 | 0.200 |
Why?
|
| Stretchers | 1 | 2021 | 1 | 0.190 |
Why?
|
| Microscopy, Confocal | 7 | 2012 | 337 | 0.190 |
Why?
|
| Cytological Techniques | 1 | 2000 | 23 | 0.190 |
Why?
|
| Diabetes Mellitus | 2 | 2006 | 694 | 0.180 |
Why?
|
| Cell Differentiation | 9 | 2010 | 1034 | 0.180 |
Why?
|
| Male | 19 | 2018 | 37283 | 0.180 |
Why?
|
| Compressive Strength | 2 | 2018 | 17 | 0.180 |
Why?
|
| Laparoscopy | 1 | 2002 | 237 | 0.180 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 53 | 0.180 |
Why?
|
| Liposomes | 1 | 2020 | 107 | 0.170 |
Why?
|
| Materials Testing | 5 | 2017 | 263 | 0.170 |
Why?
|
| Bone Marrow Cells | 3 | 2008 | 217 | 0.160 |
Why?
|
| Stem Cells | 4 | 2014 | 248 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 199 | 0.150 |
Why?
|
| Biodegradable Plastics | 1 | 2017 | 3 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 938 | 0.150 |
Why?
|
| Glutaral | 1 | 2017 | 41 | 0.150 |
Why?
|
| Coculture Techniques | 2 | 2015 | 147 | 0.150 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 78 | 0.150 |
Why?
|
| Biomechanical Phenomena | 3 | 2008 | 368 | 0.150 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 80 | 0.150 |
Why?
|
| HeLa Cells | 1 | 2017 | 237 | 0.140 |
Why?
|
| Nanostructures | 2 | 2008 | 112 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2017 | 94 | 0.140 |
Why?
|
| Cytoskeleton | 2 | 2014 | 84 | 0.140 |
Why?
|
| Heart | 3 | 2010 | 850 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 236 | 0.140 |
Why?
|
| Osteogenesis | 2 | 2008 | 152 | 0.140 |
Why?
|
| Protein Transport | 1 | 2017 | 280 | 0.140 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2016 | 7 | 0.140 |
Why?
|
| Molecular Mimicry | 1 | 2015 | 13 | 0.130 |
Why?
|
| Models, Molecular | 1 | 2018 | 546 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2016 | 104 | 0.130 |
Why?
|
| Skin | 2 | 2010 | 451 | 0.130 |
Why?
|
| Biomimetics | 1 | 2015 | 17 | 0.130 |
Why?
|
| Mice | 7 | 2020 | 8474 | 0.130 |
Why?
|
| Flufenamic Acid | 1 | 2015 | 3 | 0.130 |
Why?
|
| Biotinylation | 1 | 2015 | 27 | 0.130 |
Why?
|
| Guided Tissue Regeneration | 1 | 2015 | 6 | 0.130 |
Why?
|
| Coronary Vessels | 2 | 2009 | 313 | 0.130 |
Why?
|
| Soft Tissue Injuries | 1 | 2015 | 8 | 0.130 |
Why?
|
| Stress, Mechanical | 5 | 2012 | 208 | 0.130 |
Why?
|
| Adipocytes | 1 | 2015 | 88 | 0.130 |
Why?
|
| Cell Culture Techniques | 5 | 2010 | 189 | 0.130 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 101 | 0.130 |
Why?
|
| Specialty Boards | 1 | 2015 | 24 | 0.130 |
Why?
|
| Female | 15 | 2018 | 38021 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2015 | 156 | 0.120 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 182 | 0.120 |
Why?
|
| Cell Separation | 2 | 2013 | 132 | 0.120 |
Why?
|
| Muscle Cells | 2 | 2013 | 30 | 0.120 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 137 | 0.120 |
Why?
|
| Ink | 1 | 2014 | 8 | 0.120 |
Why?
|
| Chick Embryo | 6 | 2012 | 379 | 0.120 |
Why?
|
| Flow Cytometry | 2 | 2013 | 489 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 322 | 0.120 |
Why?
|
| Certification | 1 | 2015 | 66 | 0.120 |
Why?
|
| Time Factors | 5 | 2015 | 4655 | 0.120 |
Why?
|
| Neutrophils | 1 | 2015 | 204 | 0.120 |
Why?
|
| Climate Change | 1 | 2014 | 17 | 0.120 |
Why?
|
| Breast Implants | 2 | 2014 | 18 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2014 | 121 | 0.110 |
Why?
|
| Forecasting | 1 | 2015 | 277 | 0.110 |
Why?
|
| Pluripotent Stem Cells | 2 | 2004 | 42 | 0.110 |
Why?
|
| Cell Lineage | 3 | 2009 | 146 | 0.110 |
Why?
|
| Microscopy, Atomic Force | 3 | 2012 | 66 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2014 | 221 | 0.110 |
Why?
|
| Calcium | 2 | 2015 | 929 | 0.110 |
Why?
|
| Avian Proteins | 1 | 2012 | 23 | 0.110 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1082 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 56 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1465 | 0.110 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 37 | 0.110 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 214 | 0.110 |
Why?
|
| Models, Biological | 2 | 2008 | 981 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2010 | 246 | 0.110 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1446 | 0.110 |
Why?
|
| Insulin | 1 | 2015 | 617 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 2791 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2009 | 753 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1174 | 0.100 |
Why?
|
| Bone and Bones | 2 | 2010 | 145 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 252 | 0.100 |
Why?
|
| Viscosity | 2 | 2008 | 72 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 647 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 5 | 2010 | 236 | 0.100 |
Why?
|
| Curriculum | 1 | 2015 | 575 | 0.090 |
Why?
|
| Bone Regeneration | 1 | 2010 | 20 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 498 | 0.090 |
Why?
|
| Cell Transplantation | 1 | 2010 | 22 | 0.090 |
Why?
|
| Cyanoacrylates | 1 | 2010 | 8 | 0.090 |
Why?
|
| Cytokines | 2 | 2018 | 866 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 40 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2015 | 657 | 0.090 |
Why?
|
| Cell Adhesion | 4 | 2021 | 324 | 0.090 |
Why?
|
| Myositis Ossificans | 1 | 2009 | 6 | 0.090 |
Why?
|
| Bioreactors | 2 | 2009 | 65 | 0.090 |
Why?
|
| Limb Buds | 1 | 2009 | 8 | 0.080 |
Why?
|
| Abdominal Wall | 1 | 2009 | 20 | 0.080 |
Why?
|
| Collagen Type II | 1 | 2009 | 13 | 0.080 |
Why?
|
| Surgical Flaps | 2 | 2008 | 120 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2015 | 596 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 133 | 0.080 |
Why?
|
| Infection Control | 1 | 2010 | 101 | 0.080 |
Why?
|
| Ossification, Heterotopic | 1 | 2009 | 45 | 0.080 |
Why?
|
| Acidosis | 1 | 2008 | 31 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2009 | 123 | 0.080 |
Why?
|
| Intestinal Fistula | 1 | 2008 | 26 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2009 | 87 | 0.080 |
Why?
|
| Adult | 12 | 2014 | 21379 | 0.080 |
Why?
|
| Mesoderm | 1 | 2009 | 231 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 268 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 146 | 0.080 |
Why?
|
| Hypoxia | 1 | 2009 | 169 | 0.080 |
Why?
|
| Animal Testing Alternatives | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cicatrix | 1 | 2008 | 60 | 0.080 |
Why?
|
| Nifedipine | 1 | 2007 | 40 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2008 | 110 | 0.080 |
Why?
|
| RNA, Messenger | 5 | 2010 | 1663 | 0.070 |
Why?
|
| Electrodes, Implanted | 1 | 2008 | 98 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 320 | 0.070 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2021 | 27 | 0.070 |
Why?
|
| Isoproterenol | 1 | 2007 | 163 | 0.070 |
Why?
|
| Lidocaine | 1 | 2007 | 36 | 0.070 |
Why?
|
| Osteoblasts | 1 | 2008 | 99 | 0.070 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 10 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 371 | 0.070 |
Why?
|
| Caspase 3 | 1 | 2007 | 233 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 2798 | 0.070 |
Why?
|
| Sacrum | 1 | 2006 | 14 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2006 | 45 | 0.070 |
Why?
|
| Trauma Centers | 2 | 2007 | 197 | 0.070 |
Why?
|
| Herniorrhaphy | 1 | 2006 | 38 | 0.070 |
Why?
|
| Gels | 2 | 2007 | 55 | 0.070 |
Why?
|
| Calibration | 2 | 2008 | 73 | 0.070 |
Why?
|
| Laparotomy | 2 | 2003 | 65 | 0.070 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2006 | 36 | 0.070 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 1174 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2012 | 954 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 130 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 710 | 0.060 |
Why?
|
| Diabetes Insipidus | 1 | 2004 | 5 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2017 | 144 | 0.060 |
Why?
|
| Hexuronic Acids | 2 | 2014 | 24 | 0.060 |
Why?
|
| Glucuronic Acid | 2 | 2014 | 25 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 2 | 2004 | 102 | 0.060 |
Why?
|
| Biodegradation, Environmental | 1 | 2004 | 92 | 0.060 |
Why?
|
| Culture Media | 3 | 2010 | 155 | 0.060 |
Why?
|
| Germ Layers | 1 | 2004 | 4 | 0.060 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 51 | 0.060 |
Why?
|
| Colony-Forming Units Assay | 1 | 2004 | 78 | 0.060 |
Why?
|
| Biopsy | 1 | 2006 | 539 | 0.060 |
Why?
|
| Elasticity | 3 | 2009 | 103 | 0.060 |
Why?
|
| Culture Techniques | 1 | 2004 | 65 | 0.060 |
Why?
|
| Craniocerebral Trauma | 1 | 2004 | 50 | 0.060 |
Why?
|
| Quail | 3 | 2009 | 27 | 0.060 |
Why?
|
| Chlorides | 1 | 2004 | 68 | 0.060 |
Why?
|
| Abdominal Muscles | 1 | 2003 | 25 | 0.060 |
Why?
|
| Phosphates | 1 | 2004 | 72 | 0.060 |
Why?
|
| Hypercalcemia | 1 | 2004 | 34 | 0.060 |
Why?
|
| Hyperparathyroidism | 1 | 2004 | 40 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2006 | 311 | 0.060 |
Why?
|
| Maxillary Artery | 1 | 2003 | 5 | 0.060 |
Why?
|
| Maxillofacial Injuries | 1 | 2003 | 7 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 504 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 45 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2004 | 206 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1293 | 0.050 |
Why?
|
| Retrospective Studies | 6 | 2007 | 7268 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2550 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2002 | 66 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2002 | 57 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 4843 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2003 | 328 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2003 | 150 | 0.050 |
Why?
|
| Occupational Exposure | 1 | 2002 | 122 | 0.050 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 37 | 0.050 |
Why?
|
| Adherens Junctions | 1 | 2021 | 13 | 0.050 |
Why?
|
| Myosins | 2 | 2014 | 34 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2000 | 48 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2000 | 67 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2020 | 67 | 0.050 |
Why?
|
| Cadherins | 1 | 2021 | 93 | 0.050 |
Why?
|
| Apoptosis | 1 | 2007 | 1641 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2007 | 396 | 0.050 |
Why?
|
| Membranes, Artificial | 1 | 2000 | 88 | 0.050 |
Why?
|
| Aged | 5 | 2014 | 14842 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 82 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2077 | 0.040 |
Why?
|
| Recurrence | 1 | 2002 | 948 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 317 | 0.040 |
Why?
|
| Connexins | 2 | 2009 | 35 | 0.040 |
Why?
|
| Biomarkers | 2 | 2018 | 1593 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 236 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2021 | 431 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2003 | 596 | 0.040 |
Why?
|
| Middle Aged | 5 | 2014 | 21119 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2017 | 136 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2017 | 358 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2008 | 371 | 0.040 |
Why?
|
| Cell Communication | 1 | 2017 | 116 | 0.040 |
Why?
|
| Surface Properties | 2 | 2008 | 363 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2020 | 706 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 765 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2007 | 234 | 0.030 |
Why?
|
| Cell Movement | 2 | 2010 | 630 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2008 | 176 | 0.030 |
Why?
|
| Implant Capsular Contracture | 1 | 2014 | 2 | 0.030 |
Why?
|
| Incidence | 3 | 2004 | 1582 | 0.030 |
Why?
|
| Obesity | 1 | 2002 | 1074 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 7028 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 2014 | 29 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 294 | 0.030 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2014 | 17 | 0.030 |
Why?
|
| Sepharose | 1 | 2014 | 18 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2014 | 25 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 45 | 0.030 |
Why?
|
| Washington | 1 | 2014 | 27 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 45 | 0.030 |
Why?
|
| Algorithms | 2 | 2014 | 1195 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 83 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2014 | 152 | 0.030 |
Why?
|
| Infant | 2 | 2014 | 2891 | 0.030 |
Why?
|
| Tenascin | 1 | 2012 | 39 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 2003 | 351 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2012 | 32 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 62 | 0.030 |
Why?
|
| Cell Division | 2 | 2004 | 541 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 3187 | 0.030 |
Why?
|
| Actins | 1 | 2014 | 249 | 0.030 |
Why?
|
| Aorta | 1 | 2014 | 316 | 0.030 |
Why?
|
| Amides | 1 | 2012 | 86 | 0.030 |
Why?
|
| Heart Ventricles | 2 | 2009 | 738 | 0.030 |
Why?
|
| Lysophospholipids | 1 | 2012 | 209 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 429 | 0.020 |
Why?
|
| Risk Factors | 3 | 2008 | 5720 | 0.020 |
Why?
|
| Pyridines | 1 | 2012 | 261 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 27 | 0.020 |
Why?
|
| Survival Rate | 2 | 2004 | 1055 | 0.020 |
Why?
|
| Povidone-Iodine | 1 | 2010 | 16 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 49 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1752 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 127 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 77 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 302 | 0.020 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2009 | 25 | 0.020 |
Why?
|
| Aggrecans | 1 | 2009 | 13 | 0.020 |
Why?
|
| Pregnancy | 2 | 2006 | 2334 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 32 | 0.020 |
Why?
|
| Skin, Artificial | 1 | 2008 | 4 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1860 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 67 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2008 | 110 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 122 | 0.020 |
Why?
|
| Child | 2 | 2014 | 6401 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2008 | 75 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2009 | 158 | 0.020 |
Why?
|
| Calcification, Physiologic | 1 | 2008 | 31 | 0.020 |
Why?
|
| Heart Atria | 1 | 2009 | 206 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1015 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 71 | 0.020 |
Why?
|
| Phalloidine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2008 | 35 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2007 | 10 | 0.020 |
Why?
|
| Trypan Blue | 1 | 2007 | 24 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2007 | 13 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 232 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2007 | 20 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 95 | 0.020 |
Why?
|
| Isometric Contraction | 1 | 2007 | 33 | 0.020 |
Why?
|
| Fetus | 1 | 2008 | 157 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 8904 | 0.020 |
Why?
|
| South Carolina | 2 | 2004 | 2752 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 80 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2007 | 210 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 48 | 0.020 |
Why?
|
| Chordoma | 1 | 2006 | 9 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 282 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2007 | 191 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 682 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2008 | 343 | 0.020 |
Why?
|
| Temperature | 1 | 2007 | 340 | 0.020 |
Why?
|
| Species Specificity | 1 | 2006 | 302 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 618 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 1753 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 946 | 0.020 |
Why?
|
| Perfusion | 1 | 2006 | 131 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 100 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 384 | 0.020 |
Why?
|
| Cell Survival | 1 | 2007 | 901 | 0.020 |
Why?
|
| Rats, Inbred WF | 1 | 2004 | 14 | 0.010 |
Why?
|
| Equipment Design | 1 | 2006 | 500 | 0.010 |
Why?
|
| Myogenin | 1 | 2004 | 9 | 0.010 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2004 | 11 | 0.010 |
Why?
|
| Urodela | 1 | 2004 | 31 | 0.010 |
Why?
|
| Fasciotomy | 1 | 2003 | 12 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2004 | 71 | 0.010 |
Why?
|
| Extremities | 1 | 2004 | 49 | 0.010 |
Why?
|
| Connective Tissue | 1 | 2004 | 61 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2004 | 131 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 64 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 306 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 25 | 0.010 |
Why?
|
| Sarcomeres | 1 | 2003 | 32 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 250 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2003 | 17 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 448 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1037 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 20 | 0.010 |
Why?
|
| Myofibrils | 1 | 2003 | 35 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 85 | 0.010 |
Why?
|
| Cellular Senescence | 1 | 2004 | 112 | 0.010 |
Why?
|
| Actin Cytoskeleton | 1 | 2003 | 37 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 1047 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2004 | 121 | 0.010 |
Why?
|
| Fibrosis | 1 | 2004 | 371 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 3703 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2004 | 344 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2004 | 291 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 572 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2002 | 242 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 245 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 272 | 0.010 |
Why?
|
| Age Distribution | 1 | 2002 | 319 | 0.010 |
Why?
|
| Length of Stay | 1 | 2004 | 780 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 579 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2002 | 99 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3256 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2002 | 880 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 2324 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 5710 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2002 | 272 | 0.010 |
Why?
|
| Registries | 1 | 2002 | 730 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 1615 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2004 | 807 | 0.010 |
Why?
|
| Logistic Models | 1 | 2002 | 1419 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1549 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 565 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 2356 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 2004 | 0.010 |
Why?
|
| United States | 1 | 2002 | 7338 | 0.010 |
Why?
|